{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:56:31Z","timestamp":1777737391335,"version":"3.51.4"},"reference-count":35,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Placenta accreta spectrum (PAS) refers to a group of abnormal placental attachments in which the placenta adheres too deeply to the uterine wall, with varying degrees of invasion classified as accreta, increta, or percreta. Increased rates of uterine surgeries, advanced maternal age, and cesarean deliveries have all contributed to an increase in the incidence of PAS. Complications associated with PAS can lead to severe intrapartum or postpartum hemorrhage, hysterectomy, and significant maternal morbidity, making early diagnosis and management crucial for improving outcomes. Understanding the epidemiology and risk factors of PAS is crucial for developing early detection protocols and preventive strategies. Localized data, particularly from Bahrain, can inform targeted care approaches and optimize resource allocation, ultimately leading to improved clinical guidelines, enhanced patient education, and better healthcare outcomes for affected women. There are growing concerns about the impact of PAS on maternal health and healthcare resources in Bahrain, similar to trends observed in other regions. To improve patient education and management strategies, it is essential to comprehend the regional patterns, characteristics, and outcomes associated with PAS. However, the absence of comprehensive data specific to Bahrain hinders effective clinical decision-making and policy development. Addressing this gap is imperative for advancing maternal healthcare in the region.<\/jats:p>","DOI":"10.3390\/life15060978","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:36:00Z","timestamp":1750239360000},"page":"978","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Maternal and Clinical Outcomes of Placenta Accreta Spectrum: Insights from a Retrospective Study in Bahrain"],"prefix":"10.3390","volume":"15","author":[{"given":"Kareeza","family":"Selby Chacko","sequence":"first","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain), Busaiteen P.O. Box 15503, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Satam","family":"AlSubeaei","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain), Busaiteen P.O. Box 15503, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Sunil Nair","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain), Busaiteen P.O. Box 15503, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat","family":"Khalil Kazi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Salmaniya Medical Complex, Manama P.O. Box 12, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafiea","family":"Jeddy","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain), Busaiteen P.O. Box 15503, Bahrain"},{"name":"Department of Obstetrics and Gynecology, Royal College of Surgeons in Ireland-Bahrain (RCSI-Bahrain), Busaiteen P.O. Box 15503, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s41379-020-0569-1","article-title":"Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: Recommendations from an expert panel","volume":"33","author":"Hecht","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine (2018). Obstetric Care Consensus, No.7: Placenta Accreta Spectrum. Obstet. Gynecol., 132, e259\u2013e275.","DOI":"10.1097\/AOG.0000000000002983"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"873929","DOI":"10.1155\/2012\/873929","article-title":"Epidemiology, Etiology, Diagnosis, and Management of Placenta Accreta","volume":"2012","author":"Garmi","year":"2012","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta Accreta Spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ogc.2019.07.009","article-title":"Cesarean Scar Pregnancy: Diagnosis and Pathogenesis","volume":"46","author":"Monteagudo","year":"2019","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_7","first-page":"e44725","article-title":"A retrospective study of maternal and neonatal outcomes in placenta accreta spectrum after planned or emergency delivery from a tertiary care centre in North India","volume":"15","author":"Birendra","year":"2023","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhao, J., Li, Q., Liao, E., Shi, H., Luo, X., Zhang, L., Qi, H., Zhang, H., and Li, J. (2024). Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: A retrospective cohort study. BMC Pregnancy Childbirth, 24.","DOI":"10.1186\/s12884-024-06254-z"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/uog.13327","article-title":"Prenatal identification of invasive placentation using magnetic resonance imaging: Systematic review and meta-analysis","volume":"44","author":"Iacovella","year":"2014","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/IJWH.S53865","article-title":"Maternal and neonatal outcomes of placenta previa and placenta accreta: Three years of experience with a two-consultant approach","volume":"5","author":"Kassem","year":"2013","journal-title":"IJWH"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5005\/jp-journals-10006-1903","article-title":"Study on outcomes of pregnancy in women with Placenta Accreta Spectrum: A 10-year study in a Tertiary Care Center","volume":"13","author":"Srinivasan","year":"2021","journal-title":"J. South Asian Fed. Obstet. Gynaecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5339\/qmj.2021.8","article-title":"The intraoperative use of internal iliac artery balloon catheters in cesarean deliveries for abnormal invasive placentation: A 3-year retrospective cohort review in Doha, Qatar","volume":"2021","author":"Ahmed","year":"2021","journal-title":"Qatar Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5339\/qmj.2010.2.26","article-title":"Abstracts \u201cFrom Qatar to the World\u201d","volume":"2010","author":"Gehani","year":"2010","journal-title":"Qatar Med. J."},{"key":"ref_14","first-page":"85","article-title":"Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine-scar dehiscence","volume":"65","author":"Aryananda","year":"2024","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/aogs.13258","article-title":"Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: A systematic review and meta-analysis","volume":"97","author":"Familiari","year":"2017","journal-title":"Acta Obstet. Et Gynecol. Scand."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ajo.12932","article-title":"The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience","volume":"59","author":"Yasin","year":"2018","journal-title":"Aust. New Zealand J. Obstet. Gynaecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12409","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management","volume":"140","author":"Allen","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/14767058.2019.1609935","article-title":"Use of routine ureteral stents in cesarean hysterectomy for placenta accreta","volume":"34","author":"Crocetto","year":"2021","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","article-title":"Center of excellence for placenta accreta","volume":"212","author":"Silver","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","first-page":"1745506519878081","article-title":"Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure","volume":"15","author":"Chandraharan","year":"2019","journal-title":"Womens Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.ajog.2018.04.049","article-title":"Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta","volume":"219","author":"Marcellin","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.30699\/jogcr.9.5.516","article-title":"Placenta Accreta Spectrum; Risk Factors, Complications, Advantages and Disadvantages to Decrease Maternal Morbidity and Mortality","volume":"9","author":"Alavi","year":"2024","journal-title":"J. Obstet. Gynecol. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pan, S., Han, M., Zhai, T., Han, Y., Lu, Y., Huang, S., Zuo, Q., Jiang, Z., and Ge, Z. (2024). Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: A systematic review and meta-analysis. BMC Pregnancy Childbirth, 24.","DOI":"10.1186\/s12884-024-06658-x"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shuai, X., Gao, C., Zhang, H., Zhang, T., Li, H., Yan, Y., Yao, W., Liu, Y., and Zhang, C. (2024). Bladder involvement in placenta accreta spectrum disorders: 2D US combined with the 3D crystal Vue and MRI comparative analysis. BMC Pregnancy Childbirth, 24, Available online: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11590337\/.","DOI":"10.1186\/s12884-024-06997-9"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2232076","DOI":"10.1080\/14767058.2023.2232076","article-title":"Management strategy for urologic morbidity in surgery of placenta accreta spectrum: Stents or catheters?","volume":"36","author":"Liang","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tjog.2021.03.001","article-title":"Placenta accreta spectrum (PAS) and peripartum hysterectomy","volume":"60","author":"Horng","year":"2021","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fitzpatrick, K.E., Sellers, S., Spark, P., Kurinczuk, J.J., Brocklehurst, P., and Knight, M. (2012). Incidence and Risk Factors for Placenta Accreta\/Increta\/Percreta in the UK: A National Case-Control Study. Baradaran HR, editor. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052893"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/1471-0528.18025","article-title":"Intended Conservative Management Versus Caesarean Hysterectomy for Known or Suspected Placenta Accreta Spectrum: A Cost-Effectiveness Analysis","volume":"132","author":"Morgan","year":"2025","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2017.02.016","article-title":"Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time","volume":"216","author":"Shamshirsaz","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.09.001","article-title":"Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum","volume":"224","author":"Shainker","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1055\/s-0034-1372422","article-title":"Bakri Balloon in the Management of Postpartum Hemorrhage: A Review","volume":"31","author":"Wright","year":"2014","journal-title":"Am. J. Perinatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajog.2025.01.030","article-title":"Conservative management of placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: A systematic review and meta-analysis","volume":"232","author":"Hessami","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/AOG.0b013e3181d066d4","article-title":"Maternal outcome after conservative treatment of placenta accreta","volume":"115","author":"Sentilhes","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/AOG.0000000000001113","article-title":"Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial","volume":"126","author":"Salim","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/TA.0000000000003090","article-title":"A multidisciplinary approach and implementation of a specialized hemorrhage control team improves outcomes for placenta accreta spectrum","volume":"90","author":"Manzano","year":"2021","journal-title":"J. Trauma Acute Care Surg."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/6\/978\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:54:16Z","timestamp":1760032456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/6\/978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["life15060978"],"URL":"https:\/\/doi.org\/10.3390\/life15060978","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}